NFκB mediates cisplatin resistance through histone modifications in head and neck squamous cell carcinoma (HNSCC)☆

Cisplatin-based chemotherapy is the standard treatment of choice for head and neck squamous cell carcinoma (HNSCC). The efficiency of platinum-based therapies is directly influenced by the development of tumor resistance. Multiple signaling pathways have been linked to tumor resistance, including ac...

Full description

Bibliographic Details
Main Authors: Almeida, Luciana O., Abrahao, Aline C., Rosselli-Murai, Luciana K., Giudice, Fernanda S., Zagni, Chiara, Leopoldino, Andreia M., Squarize, Cristiane H., Castilho, Rogerio M.
Format: Online
Language:English
Published: Elsevier 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907686/